Abstract
Traditionally, scientists have focused on structural changes in DNA sequences, such as mutations and deletions, as the cause for altered patterns of gene expression in human cancer. However, a recent explosion of studies indicates that epigenetic changes can be equally important in controlling gene expression. For example, global changes in DNA methylation occur during the progression of breast cancer. These changes include hypomethylation and hypermethylation of chromosomal regions and specific genes that are implicated in the genesis of breast cancer. As an example, we will pay particular attention to two genes, estrogen and progesterone receptor, which have long been associated with breast cancer initiation and progression. Identifying and characterizing these epigenetic modifications may lead to improvements in early detection, prognosis and design of novel therapies for a disease that is one of the leading causes of cancer death among women. This review will describe the changes in DNA meth ylation that have been identified in breast cancer thus far, and their functional consequences, including gene silencing, uncontrolled cell growth, genomic instability and hypermutability. Further, we will discuss the clinical ramifications of these findings.
Keywords: Gene expression, Breast Cancer, DNA methylaion, CpG Island, DNMT, Human cancer, Cell growth, Differentiation, Mammary derived growth inhibitor MDGI, Genetic Stability
Current Genomics
Title: DNA Methylation and Breast Cancer
Volume: 1 Issue: 1
Author(s): A. T. Ferguson and S. J. Nass
Affiliation:
Keywords: Gene expression, Breast Cancer, DNA methylaion, CpG Island, DNMT, Human cancer, Cell growth, Differentiation, Mammary derived growth inhibitor MDGI, Genetic Stability
Abstract: Traditionally, scientists have focused on structural changes in DNA sequences, such as mutations and deletions, as the cause for altered patterns of gene expression in human cancer. However, a recent explosion of studies indicates that epigenetic changes can be equally important in controlling gene expression. For example, global changes in DNA methylation occur during the progression of breast cancer. These changes include hypomethylation and hypermethylation of chromosomal regions and specific genes that are implicated in the genesis of breast cancer. As an example, we will pay particular attention to two genes, estrogen and progesterone receptor, which have long been associated with breast cancer initiation and progression. Identifying and characterizing these epigenetic modifications may lead to improvements in early detection, prognosis and design of novel therapies for a disease that is one of the leading causes of cancer death among women. This review will describe the changes in DNA meth ylation that have been identified in breast cancer thus far, and their functional consequences, including gene silencing, uncontrolled cell growth, genomic instability and hypermutability. Further, we will discuss the clinical ramifications of these findings.
Export Options
About this article
Cite this article as:
Ferguson T. A. and Nass J. S., DNA Methylation and Breast Cancer, Current Genomics 2000; 1 (1) . https://dx.doi.org/10.2174/1389202003351652
DOI https://dx.doi.org/10.2174/1389202003351652 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
Genomic Insights into Oncology: Harnessing Machine Learning for Breakthroughs in Cancer Genomics.
This special issue aims to explore the cutting-edge intersection of genomics and oncology, with a strong emphasis on original data and experimental validation. While maintaining the focus on how machine learning and advanced data analysis techniques are revolutionizing our understanding and treatment of cancer, this issue will prioritize contributions that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel and Emerging Targeted Therapies of Colorectal Cancer
Current Clinical Pharmacology Retrometabolic Approach for Designing Personalized Anti- Cancer Drug Molecules for Controlling Breast Cancer Resulted by BRCA1 Mutations
Current Pharmacogenomics and Personalized Medicine Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
Current Cancer Drug Targets Focal Adhesion Kinase Controls Prostate Cancer Progression Via Intrinsic Kinase and Scaffolding Functions
Anti-Cancer Agents in Medicinal Chemistry Bioactives from Marine Organisms and their Potential Role as Matrix Metalloproteinase Inhibitors
Current Pharmaceutical Design Targeting DNA Minor Groove by Hybrid Molecules as Anticancer Agents
Current Medicinal Chemistry Rational Design and Development of HDAC Inhibitors for Breast Cancer Treatment
Current Pharmaceutical Design Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways
Current Stem Cell Research & Therapy Natural Plant Extracts as Potential Therapeutic Agents for the Treatment of Cancer
Current Topics in Medicinal Chemistry Capillary Electrophoresis with Mass Spectrometry: Applications to Metabolomic Analysis
Current Metabolomics Interlinking of Hypoxia and Estrogen in Thyroid Cancer Progression
Current Medicinal Chemistry Nanoradiopharmaceuticals for Nanomedicine: Building the Future
Recent Patents on Nanomedicine Alpha-Terpineol as Antitumor Candidate in Pre-Clinical Studies
Anti-Cancer Agents in Medicinal Chemistry Targeting Aldose Reductase for the Treatment of Cancer
Current Cancer Drug Targets Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer
Current Cancer Drug Targets Roles of Casein Kinase I η and δ in Gastrointestinal Cancers: Potential New Screening Markers and Drug Targets
Current Cancer Therapy Reviews Editorial (Thematic Issue: Cancer Biomarkers from Bench to Bedside)
Current Cancer Drug Targets Pain Management in Hematological Patients with Major Organ Dysfunctions and Comorbid Illnesses
Cardiovascular & Hematological Agents in Medicinal Chemistry New Drugs for Immune Targeting
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Andrographolide Inhibits Proliferation of Colon Cancer SW-480 Cells <i>via</i> Downregulating Notch Signaling Pathway
Anti-Cancer Agents in Medicinal Chemistry